Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

NCT07487077 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1071

Enrollment

OTHER

Sponsor class

Conditions

Cholera Vaccination

Interventions

DRUG: Euvichol-S Oral Cholera Vaccine

Sponsor

Albert B. Sabin Vaccine Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]